Investigational PD-1 inhibitors for advanced non-small lung cancer: new players in a shifting paradigm

被引：7

作者：

Ghanem, Sassine ^{[1
]}

Valecha, Gautam Krichore ^{[2
]}

Hossri, Sami ^{[1
]}

Ibrahim, Uroosa ^{[2
]}

Atallah, Jean Paul ^{[2
]}

机构：

[1] Northwell Hlth, Dept Internal Med, Staten Isl Univ Hosp, 475 Seaview Ave, Staten Isl, NY 10309 USA

[2] Northwell Hlth, Dept Hematol & Oncol, Staten Isl Univ Hosp, Staten Isl, NY USA

来源：

EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2017年 / 26卷 / 12期

关键词：

Immunotherapy; non-small cell lung cancer; PD-1; inhibitors; PD-L1; PDR001; REGN2810; MEDI0680; 244C8; 388D4; PEMBROLIZUMAB; IMMUNOTHERAPY;

D O I：

10.1080/13543784.2017.1395019

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1317 / 1319

页数：3

共 12 条

[1]

[Anonymous], STUD REGN 2810 COMP

[2]

[Anonymous], ANN ONCOL S6

[3] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Borghaei, H. ;

Paz-Ares, L. ;

Horn, L. ;

Spigel, D. R. ;

Steins, M. ;

Ready, N. E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Arrieta, O. ;

Burgio, M. A. ;

Fayette, J. ;

Lena, H. ;

Poddubskaya, E. ;

Gerber, D. E. ;

Gettinger, S. N. ;

Rudin, C. M. ;

Rizvi, N. ;

Crino, L. ;

Blumenschein, G. R. ;

Antonia, S. J. ;

Dorange, C. ;

Harbison, C. T. ;

Finckenstein, F. Graf ;

Brahmer, J. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639

[4]

Lee JY, 2016, NAT COMMUN, V7

[5] Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges [J].

Leprieur, Etienne Giroux ;

Dumenil, Coraline ;

Julie, Catherine ;

Giraud, Violaine ;

Dumoulin, Jennifer ;

Labrune, Sylvie ;

Chinet, Thierry .

EUROPEAN JOURNAL OF CANCER, 2017, 78 :16-23

[6]

NAING A, 2016, J CLIN ONCOL S, V34

[7] A first-in-human study of REGN2810, a monoclonal, fully human antibody to programmed death-1 (PD-1), in combination with immunomodulators including hypofractionated radiotherapy (hfRT) [J].

Papadopoulos, Kyriakos P. ;

Crittenden, Marka R. ;

Johnson, Melissa Lynne ;

Lockhart, Albert C. ;

Moore, Kathleen N. ;

Falchook, Gerald Steven ;

Formenti, Silvia ;

Carvajal, Richard D. ;

Leidner, Rom S. ;

Naing, Aung ;

Rosen, Lee S. ;

Weiss, Glen J. ;

Iii, Wilson Caldwell ;

Gao, Bo ;

Paccaly, Anne ;

Stankevich, Elizabeth ;

Trail, Pamela ;

Fury, Matthew G. ;

Lowy, Israel .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

[8] Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer [J].

Reck, Martin ;

Rodriguez-Abreu, Delvys ;

Robinson, Andrew G. ;

Hui, Rina ;

Csoszi, Tibor ;

Fulop, Andrea ;

Gottfried, Maya ;

Peled, Nir ;

Tafreshi, Ali ;

Cuffe, Sinead ;

O'Brien, Mary ;

Rao, Suman ;

Hotta, Katsuyuki ;

Leiby, Melanie A. ;

Lubiniecki, Gregory M. ;

Shentu, Yue ;

Rangwala, Reshma ;

Brahmer, Julie R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) :1823-1833

[9] Acquired resistance to immunotherapy and future challenges [J].

Restifo, Nicholas P. ;

Smyth, Mark J. ;

Snyder, Alexandra .

NATURE REVIEWS CANCER, 2016, 16 (02) :121-126

[10] Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma [J].

Ribas, Antoni ;

Hamid, Omid ;

Daud, Adil ;

Hodi, F. Stephen ;

Wolchok, Jedd D. ;

Kefford, Richard ;

Joshua, Anthony M. ;

Patnaik, Amita ;

Hwu, Wen-Jen ;

Weber, Jeffrey S. ;

Gangadhar, Tara C. ;

Hersey, Peter ;

Dronca, Roxana ;

Joseph, Richard W. ;

Zarour, Hassane ;

Chmielowski, Bartosz ;

Lawrence, Donald P. ;

Algazi, Alain ;

Rizvi, Naiyer A. ;

Hoffner, Brianna ;

Mateus, Christine ;

Gergich, Kevin ;

Lindia, Jill A. ;

Giannotti, Maxine ;

Li, Xiaoyun Nicole ;

Ebbinghaus, Scot ;

Kang, S. Peter ;

Robert, Caroline .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (15) :1600-1609

← 1 2 →